Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e‑Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

JHOP - June 2021 Vol 11, No 3

Symptom Management Overview

HOPA Highlights

Case Reports

Pegaspargase-Induced Diabetic Ketoacidosis in a Patient with Acute Lymphoblastic Leukemia

Ellen Madarang, PharmD, BCOP; Leslie Gallardo, PharmD, BCPS; Terrence Bradley, MD

Original Article

Denosumab for First-Line Treatment of Hypercalcemia Associated with Malignancy: Retrospective Analysis

Katherine P. Morgan, PharmD, BCOP, CPP; Yujiao Sun, PharmD; Allison Deal; Jared Weiss, MD; Amber Cipriani, PharmD, BCOP

Jessica M. Tran, PharmD, BCPS; Ni-Chi Wu, PharmD, BCOP, BCPS; Rajkumar J. Sevak, PhD, RPh; Pankaj Gupta, MD, FACP

Pharmacy Resident–Led Medication Reconciliation and Patient Education Service in Adults with Leukemia Receiving Anticancer Oral Agents: A Pilot Study

Lily Y. Jia, PharmD, BCOP; Jessie Signorelli, PharmD, BCOP; Samantha O. Luk, PharmD, BCOP; E. Bridget Kim, PharmD, BCPS, BCOP; Gayle C. Blouin, PharmD, BCOP

FDA Oncology Update

Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation

Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations

Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma

Jemperli First FDA-Approved Immunotherapy for Advanced Endometrial Cancer with dMMR Biomarker

Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer

Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer

Trodelvy Receives New Indication for Advanced Urothelial Cancer

Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma

From the Literature

Daily Aspirin Does Not Lower Colorectal Cancer Risk When Started After Age 70

Adjuvant Nivolumab Therapy Prolongs Disease-Free Survival in Patients with Esophageal Cancer